ACETAMINOPHEN, CAFFEINE

ACETAMINOPHEN, CAFFEINE was reported 7820 times

These side effects are most commonly reported by patients taking ACETAMINOPHEN, CAFFEINE:

# Side effect Count
0 DRUG INEFFECTIVE 2064
1 HEADACHE 587
2 NAUSEA 427
3 FATIGUE 375
4 PRODUCT USE IN UNAPPROVED INDICATION 306
5 MIGRAINE 287
6 PAIN 245
7 DIZZINESS 239
8 VOMITING 214
9 DIARRHOEA 213
10 INSOMNIA 210
11 ABDOMINAL PAIN UPPER 196
12 ABDOMINAL DISCOMFORT 189
13 MALAISE 185
14 OFF LABEL USE 171
15 ANXIETY 167
16 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 157
17 DYSPNOEA 153
18 ARTHRALGIA 152
19 PRODUCT QUALITY ISSUE 151
20 FEELING ABNORMAL 150
21 MEDICATION OVERUSE HEADACHE 149
22 FALL 146
23 DRUG DEPENDENCE 142
24 INCORRECT DOSE ADMINISTERED 132
25 BACK PAIN 124
26 ASTHENIA 123
27 CONSTIPATION 118
28 PAIN IN EXTREMITY 118
29 THERAPEUTIC RESPONSE UNEXPECTED 117
30 PRODUCT USE ISSUE 113
31 CONDITION AGGRAVATED 112
32 DEPRESSION 112
33 CHRONIC KIDNEY DISEASE 111
34 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 111
35 DRUG HYPERSENSITIVITY 107
36 PRURITUS 104
37 RASH 97
38 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96
39 SOMNOLENCE 94
40 OVERDOSE 91
41 COUGH 90
42 GAIT DISTURBANCE 88
43 RENAL FAILURE 88
44 TREMOR 88
45 MUSCLE SPASMS 85
46 WEIGHT DECREASED 85
47 HYPOAESTHESIA 83
48 CHEST PAIN 82
49 DECREASED APPETITE 81
50 DYSPEPSIA 81
51 GASTRIC DISORDER 81
52 PARAESTHESIA 81
53 PALPITATIONS 79
54 INJECTION SITE PAIN 77
55 MEMORY IMPAIRMENT 76
56 PRODUCT DOSE OMISSION ISSUE 75
57 MYALGIA 73
58 ACUTE KIDNEY INJURY 72
59 HYPERTENSION 72
60 PYREXIA 72
61 INTENTIONAL PRODUCT MISUSE 70
62 PERIPHERAL SWELLING 69
63 GASTROOESOPHAGEAL REFLUX DISEASE 68
64 WEIGHT INCREASED 68
65 BLOOD PRESSURE INCREASED 67
66 ABDOMINAL PAIN 65
67 ALOPECIA 64
68 PNEUMONIA 63
69 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63
70 UNDERDOSE 61
71 URTICARIA 61
72 CONTUSION 60
73 NASOPHARYNGITIS 60
74 ULCER 60
75 SINUSITIS 57
76 DEATH 56
77 DRUG EFFECT INCOMPLETE 56
78 LOSS OF CONSCIOUSNESS 56
79 URINARY TRACT INFECTION 56
80 DRUG DOSE OMISSION 55
81 HEART RATE INCREASED 55
82 HYPERSENSITIVITY 55
83 ERYTHEMA 54
84 ILLNESS 54
85 VISION BLURRED 54
86 BALANCE DISORDER 52
87 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52
88 CEREBROVASCULAR ACCIDENT 51
89 CHILLS 51
90 DRUG EFFECT VARIABLE 50
91 INCORRECT DRUG ADMINISTRATION DURATION 50
92 OROPHARYNGEAL PAIN 50
93 CONTRAINDICATED PRODUCT ADMINISTERED 48
94 ULCER HAEMORRHAGE 48
95 ANAEMIA 47
96 ARTHRITIS 47
97 GASTRIC ULCER 47
98 DEHYDRATION 46
99 DRUG ADMINISTRATION ERROR 46
100 HOT FLUSH 46
101 INJECTION SITE ERYTHEMA 46
102 SEIZURE 46
103 CHEST DISCOMFORT 45
104 FEELING JITTERY 44
105 ADVERSE EVENT 43
106 MUSCULOSKELETAL STIFFNESS 43
107 ASTHMA 42
108 DYSPHAGIA 42
109 MULTIPLE SCLEROSIS RELAPSE 42
110 ABDOMINAL DISTENSION 41
111 ILL-DEFINED DISORDER 41
112 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41
113 NECK PAIN 41
114 VISUAL IMPAIRMENT 41
115 HYPERHIDROSIS 40
116 CONFUSIONAL STATE 39
117 INFLUENZA LIKE ILLNESS 39
118 MUSCULAR WEAKNESS 39
119 PRODUCT SUBSTITUTION ISSUE 39
120 ADVERSE DRUG REACTION 38
121 COVID-19 38
122 FLUSHING 38
123 GASTROINTESTINAL DISORDER 38
124 INFLUENZA 38
125 MYOCARDIAL INFARCTION 38
126 PSORIASIS 38
127 VERTIGO 38
128 EXPOSURE DURING PREGNANCY 37
129 INJECTION SITE BRUISING 37
130 LIVER DISORDER 37
131 STRESS 37
132 TINNITUS 37
133 EXTRA DOSE ADMINISTERED 36
134 HAEMORRHAGE 36
135 HYPOTENSION 35
136 HOSPITALISATION 34
137 BURNING SENSATION 33
138 BONE PAIN 32
139 DRUG EFFECT DECREASED 32
140 GASTROINTESTINAL HAEMORRHAGE 32
141 JOINT SWELLING 32
142 PRODUCT DOSE OMISSION 32
143 SWELLING 32
144 AMNESIA 31
145 END STAGE RENAL DISEASE 31
146 INTENTIONAL PRODUCT USE ISSUE 31
147 SWELLING FACE 31
148 DRUG INTOLERANCE 30
149 DYSGEUSIA 30
150 FLATULENCE 30
151 INFECTION 30
152 MEDICATION ERROR 30
153 NERVOUSNESS 30
154 NEUROPATHY PERIPHERAL 30
155 BRONCHITIS 29
156 PULMONARY EMBOLISM 29
157 SUICIDAL IDEATION 29
158 HAEMOGLOBIN DECREASED 28
159 MATERNAL EXPOSURE DURING PREGNANCY 28
160 OEDEMA PERIPHERAL 28
161 POOR QUALITY SLEEP 28
162 PRODUCT PHYSICAL ISSUE 28
163 RHEUMATOID ARTHRITIS 28
164 SYNCOPE 28
165 WHITE BLOOD CELL COUNT DECREASED 28
166 DRY MOUTH 27
167 SLEEP DISORDER 27
168 SPEECH DISORDER 27
169 THROMBOSIS 27
170 ATRIAL FIBRILLATION 26
171 DYSPHONIA 26
172 FOETAL EXPOSURE DURING PREGNANCY 26
173 MOBILITY DECREASED 26
174 CARDIAC DISORDER 25
175 DIABETES MELLITUS 25
176 DISTURBANCE IN ATTENTION 25
177 EPISTAXIS 25
178 EXPIRED PRODUCT ADMINISTERED 25
179 FEELING HOT 25
180 GASTRIC HAEMORRHAGE 25
181 HALLUCINATION 25
182 INJECTION SITE PRURITUS 25
183 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25
184 ACNE 24
185 DEPRESSED MOOD 24
186 DRUG INTERACTION 24
187 HAEMATOCHEZIA 24
188 ROAD TRAFFIC ACCIDENT 24
189 BLOOD GLUCOSE INCREASED 23
190 DRY SKIN 23
191 LIMB INJURY 23
192 MUSCULOSKELETAL PAIN 23
193 NEPHROLITHIASIS 23
194 PAIN IN JAW 23
195 RENAL DISORDER 23
196 THERAPY CESSATION 23
197 EYE PAIN 22
198 MULTIPLE SCLEROSIS 22
199 PANIC ATTACK 22
200 PLATELET COUNT DECREASED 22
201 RENAL INJURY 22
202 CATARACT 21
203 COGNITIVE DISORDER 21
204 GAIT INABILITY 21
205 HYPERSOMNIA 21
206 LETHARGY 21
207 CYSTITIS 20
208 DRUG EFFECT LESS THAN EXPECTED 20
209 HEPATIC ENZYME INCREASED 20
210 INJECTION SITE SWELLING 20
211 INJURY 20
212 LIMB DISCOMFORT 20
213 RHINORRHOEA 20
214 SINUS DISORDER 20
215 TUBULOINTERSTITIAL NEPHRITIS 20
216 UNEVALUABLE EVENT 20
217 WITHDRAWAL SYNDROME 20
218 FIBROMYALGIA 19
219 GENERAL PHYSICAL HEALTH DETERIORATION 19
220 HERPES ZOSTER 19
221 POLLAKIURIA 19
222 PRODUCT COMPLAINT 19
223 PRODUCT STORAGE ERROR 19
224 PSORIATIC ARTHROPATHY 19
225 SKIN BURNING SENSATION 19
226 SKIN DISCOLOURATION 19
227 CRYING 18
228 DEVICE MALFUNCTION 18
229 DISEASE RECURRENCE 18
230 DRUG WITHDRAWAL SYNDROME 18
231 EMOTIONAL DISTRESS 18
232 INTERVERTEBRAL DISC PROTRUSION 18
233 NASAL CONGESTION 18
234 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18
235 STOMATITIS 18
236 THROAT IRRITATION 18
237 ABNORMAL DREAMS 17
238 BACK DISORDER 17
239 CARDIAC FAILURE CONGESTIVE 17
240 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17
241 DEEP VEIN THROMBOSIS 17
242 DEVICE DIFFICULT TO USE 17
243 DISEASE PROGRESSION 17
244 EMERGENCY CARE EXAMINATION 17
245 EYE SWELLING 17
246 HEAD INJURY 17
247 IRRITABILITY 17
248 LIVER INJURY 17
249 OSTEOARTHRITIS 17
250 RASH PRURITIC 17
251 SEASONAL ALLERGY 17
252 THERAPY NON-RESPONDER 17
253 ACCIDENTAL EXPOSURE TO PRODUCT 16
254 ARTHROPATHY 16
255 CELLULITIS 16
256 DISCOMFORT 16
257 GASTRITIS 16
258 INJECTION SITE HAEMORRHAGE 16
259 JOINT STIFFNESS 16
260 RESPIRATORY FAILURE 16
261 THERAPEUTIC RESPONSE DECREASED 16
262 VAGINAL HAEMORRHAGE 16
263 ANGER 15
264 BLOOD POTASSIUM DECREASED 15
265 CEREBRAL HAEMORRHAGE 15
266 CHOLELITHIASIS 15
267 DRUG DOSE OMISSION BY DEVICE 15
268 DYSSTASIA 15
269 IMPAIRED HEALING 15
270 INJECTION SITE REACTION 15
271 INTENTIONAL OVERDOSE 15
272 MENTAL DISORDER 15
273 MUSCLE TIGHTNESS 15
274 NIGHT SWEATS 15
275 OEDEMA 15
276 PARAESTHESIA ORAL 15
277 PHOTOPHOBIA 15
278 RASH MACULAR 15
279 SKIN EXFOLIATION 15
280 STAPHYLOCOCCAL INFECTION 15
281 TACHYCARDIA 15
282 THERAPY INTERRUPTED 15
283 TOOTH DISORDER 15
284 URINARY INCONTINENCE 15
285 WHEEZING 15
286 AGITATION 14
287 ASPARTATE AMINOTRANSFERASE INCREASED 14
288 DENTAL CARIES 14
289 DRUG EFFECT DELAYED 14
290 EAR INFECTION 14
291 EAR PAIN 14
292 FLUID RETENTION 14
293 GASTRIC ULCER HAEMORRHAGE 14
294 HAEMATEMESIS 14
295 HYPOAESTHESIA ORAL 14
296 HYPOTHYROIDISM 14
297 IMPAIRED WORK ABILITY 14
298 INCORRECT PRODUCT ADMINISTRATION DURATION 14
299 LIP SWELLING 14
300 MOOD SWINGS 14
301 NEOPLASM MALIGNANT 14
302 NEPHROGENIC ANAEMIA 14
303 RENAL IMPAIRMENT 14
304 RESTLESS LEGS SYNDROME 14
305 THERAPEUTIC RESPONSE SHORTENED 14
306 TOOTH FRACTURE 14
307 TOOTHACHE 14
308 TREATMENT FAILURE 14
309 UPPER RESPIRATORY TRACT INFECTION 14
310 VITAMIN D DEFICIENCY 14
311 BLISTER 13
312 CHROMATURIA 13
313 CROHN^S DISEASE 13
314 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13
315 EYE PRURITUS 13
316 FOOT FRACTURE 13
317 FUNGAL INFECTION 13
318 GASTRITIS EROSIVE 13
319 IMPAIRED DRIVING ABILITY 13
320 INFUSION RELATED REACTION 13
321 JOINT INJURY 13
322 LIVER FUNCTION TEST INCREASED 13
323 NIGHTMARE 13
324 POSTNATAL GROWTH RESTRICTION 13
325 PRODUCT DOSE OMISSION IN ERROR 13
326 REBOUND ACID HYPERSECRETION 13
327 RECTAL HAEMORRHAGE 13
328 SKIN DISORDER 13
329 APHASIA 12
330 BLINDNESS 12
331 CHOKING 12
332 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12
333 DEVICE DISLOCATION 12
334 DYSMENORRHOEA 12
335 DYSURIA 12
336 EMOTIONAL DISORDER 12
337 EPIGASTRIC DISCOMFORT 12
338 EXPIRED DRUG ADMINISTERED 12
339 FAECES DISCOLOURED 12
340 FEELING COLD 12
341 GASTRIC PERFORATION 12
342 INTESTINAL OBSTRUCTION 12
343 KIDNEY INFECTION 12
344 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12
345 LIVE BIRTH 12
346 LOWER RESPIRATORY TRACT INFECTION 12
347 LYMPHADENOPATHY 12
348 MICTURITION URGENCY 12
349 OSTEOPOROSIS 12
350 PRODUCT ADMINISTRATION ERROR 12
351 PRODUCT USE COMPLAINT 12
352 PRURITUS GENERALISED 12
353 RETCHING 12
354 SCIATICA 12
355 SEPSIS 12
356 TOOTH LOSS 12
357 TRANSIENT ISCHAEMIC ATTACK 12
358 TYPE 2 DIABETES MELLITUS 12
359 URINARY RETENTION 12
360 VISUAL ACUITY REDUCED 12
361 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11
362 ACCIDENTAL OVERDOSE 11
363 ALANINE AMINOTRANSFERASE INCREASED 11
364 ANAL INCONTINENCE 11
365 APPLICATION SITE ERYTHEMA 11
366 BLOOD PRESSURE DECREASED 11
367 BRAIN NEOPLASM 11
368 C-REACTIVE PROTEIN INCREASED 11
369 COLITIS 11
370 DIVERTICULITIS 11
371 DYSPNOEA EXERTIONAL 11
372 GOUT 11
373 INFUSION SITE PAIN 11
374 INITIAL INSOMNIA 11
375 IRRITABLE BOWEL SYNDROME 11
376 LABORATORY TEST ABNORMAL 11
377 MOOD ALTERED 11
378 NEUTROPENIA 11
379 PRODUCT ADHESION ISSUE 11
380 PRODUCTIVE COUGH 11
381 QUALITY OF LIFE DECREASED 11
382 SKIN LESION 11
383 SLEEP APNOEA SYNDROME 11
384 SURGERY 11
385 THERAPEUTIC PRODUCT EFFECT DECREASED 11
386 THERAPEUTIC PRODUCT EFFECT VARIABLE 11
387 THINKING ABNORMAL 11
388 THROAT TIGHTNESS 11
389 TREATMENT NONCOMPLIANCE 11
390 ABDOMINAL PAIN LOWER 10
391 BLADDER DISORDER 10
392 BLOOD CHOLESTEROL INCREASED 10
393 BOWEL MOVEMENT IRREGULARITY 10
394 DEVICE ISSUE 10
395 DRY EYE 10
396 EUPHORIC MOOD 10
397 GASTROINTESTINAL PAIN 10
398 HAEMORRHOIDS 10
399 HEAD DISCOMFORT 10
400 INFLAMMATION 10
401 INSURANCE ISSUE 10
402 MACULAR DEGENERATION 10
403 MOVEMENT DISORDER 10
404 OCULAR HYPERAEMIA 10
405 PAPILLOEDEMA 10
406 PLEURAL EFFUSION 10
407 RASH ERYTHEMATOUS 10
408 RED BLOOD CELL COUNT DECREASED 10
409 RESPIRATORY TRACT INFECTION 10
410 RESTLESSNESS 10
411 RIB FRACTURE 10
412 ROTATOR CUFF SYNDROME 10
413 SPINAL OPERATION 10
414 THERAPEUTIC RESPONSE CHANGED 10
415 TOXICITY TO VARIOUS AGENTS 10
416 ACTIVITIES OF DAILY LIVING IMPAIRED 9
417 ACUTE RESPIRATORY FAILURE 9
418 BARRETT^S OESOPHAGUS 9
419 BONE DISORDER 9
420 DEAFNESS 9
421 DRUG SCREEN POSITIVE 9
422 EYE DISORDER 9
423 FEAR 9
424 FEEDING DISORDER 9
425 FEELING DRUNK 9
426 FEMUR FRACTURE 9
427 FORMICATION 9
428 HEPATIC STEATOSIS 9
429 HERNIA 9
430 HIATUS HERNIA 9
431 HYPOACUSIS 9
432 IDIOPATHIC INTRACRANIAL HYPERTENSION 9
433 INCREASED TENDENCY TO BRUISE 9
434 LYMPHOCYTE COUNT DECREASED 9
435 MENTAL STATUS CHANGES 9
436 MUSCULOSKELETAL DISCOMFORT 9
437 OVARIAN CYST 9
438 PRESYNCOPE 9
439 PSYCHOTIC DISORDER 9
440 PULMONARY OEDEMA 9
441 REBOUND EFFECT 9
442 TRANSFUSION 9
443 UPPER LIMB FRACTURE 9
444 WOUND 9
445 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9
446 BLOOD IRON DECREASED 8
447 BLOOD MAGNESIUM DECREASED 8
448 CENTRAL NERVOUS SYSTEM LESION 8
449 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8
450 COMA 8
451 CORONARY ARTERY DISEASE 8
452 DERMATITIS CONTACT 8
453 DISORIENTATION 8
454 DISSOCIATION 8
455 DYSARTHRIA 8
456 EXOSTOSIS 8
457 GLAUCOMA 8
458 HAEMATURIA 8
459 HEPATIC FAILURE 8
460 HEREDITARY ANGIOEDEMA 8
461 INJECTION SITE MASS 8
462 LACERATION 8
463 LIVER FUNCTION TEST ABNORMAL 8
464 MALIGNANT NEOPLASM PROGRESSION 8
465 MENINGITIS ASEPTIC 8
466 MENORRHAGIA 8
467 MUSCLE TWITCHING 8
468 MUSCULOSKELETAL CHEST PAIN 8
469 OCULAR DISCOMFORT 8
470 ORAL PAIN 8
471 PARKINSON^S DISEASE 8
472 PERIPHERAL COLDNESS 8
473 PHARYNGEAL OEDEMA 8
474 PROCEDURAL PAIN 8
475 SCAR 8
476 SKIN CANCER 8
477 SPINAL FRACTURE 8
478 SUICIDE ATTEMPT 8
479 SWOLLEN TONGUE 8
480 THYROID DISORDER 8
481 ABASIA 7
482 AGEUSIA 7
483 ANAPHYLACTIC REACTION 7
484 ANHEDONIA 7
485 APPLICATION SITE BURN 7
486 ARRHYTHMIA 7
487 BLEPHAROSPASM 7
488 BLOOD CALCIUM INCREASED 7
489 BLOOD GLUCOSE DECREASED 7
490 BLOOD URINE PRESENT 7
491 CARDIAC FAILURE 7
492 CEREBRAL DISORDER 7
493 COAGULOPATHY 7
494 COORDINATION ABNORMAL 7
495 DEMENTIA 7
496 DEPENDENCE 7
497 DEPRESSED LEVEL OF CONSCIOUSNESS 7
498 DIPLOPIA 7
499 DRUG PRESCRIBING ERROR 7
500 EATING DISORDER 7
501 EPILEPSY 7
502 ERUCTATION 7
503 ESSENTIAL HYPERTENSION 7
504 EYE IRRITATION 7
505 FULL BLOOD COUNT DECREASED 7
506 GESTATIONAL DIABETES 7
507 GLOSSODYNIA 7
508 HAEMOPTYSIS 7
509 HALLUCINATION, VISUAL 7
510 HEART RATE DECREASED 7
511 HEART RATE IRREGULAR 7
512 HEMIPARESIS 7
513 HEPATOTOXICITY 7
514 HIP FRACTURE 7
515 HYPERURICAEMIA 7
516 HYPOKALAEMIA 7
517 HYPOPHAGIA 7
518 IMPAIRED GASTRIC EMPTYING 7
519 INCONTINENCE 7
520 INCORRECT DOSAGE ADMINISTERED 7
521 INCREASED APPETITE 7
522 INJECTION SITE RASH 7
523 INTENTIONAL UNDERDOSE 7
524 INTRACRANIAL VENOUS SINUS STENOSIS 7
525 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 7
526 LACRIMATION INCREASED 7
527 LUNG DISORDER 7
528 MENSTRUATION IRREGULAR 7
529 MIDDLE INSOMNIA 7
530 MIGRAINE WITH AURA 7
531 NERVE COMPRESSION 7
532 NO ADVERSE EVENT 7
533 OESOPHAGEAL DISORDER 7
534 OPTIC DISC HAEMORRHAGE 7
535 ORAL DISCOMFORT 7
536 OSTEOMYELITIS 7
537 PHARMACEUTICAL PRODUCT COMPLAINT 7
538 PHOTOPSIA 7
539 PNEUMOTHORAX 7
540 PRE-EXISTING CONDITION IMPROVED 7
541 PRODUCT ADMINISTRATION INTERRUPTED 7
542 PRODUCT ODOUR ABNORMAL 7
543 RENAL PAIN 7
544 SCOLIOSIS 7
545 SEDATION 7
546 SENSORY DISTURBANCE 7
547 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7
548 SNORING 7
549 SOMNAMBULISM 7
550 SPINAL OSTEOARTHRITIS 7
551 TENDERNESS 7
552 THERAPEUTIC PRODUCT EFFECT DELAYED 7
553 THROMBOCYTOPENIA 7
554 TOOTH INFECTION 7
555 UNRESPONSIVE TO STIMULI 7
556 UPPER GASTROINTESTINAL HAEMORRHAGE 7
557 VIRAL INFECTION 7
558 WRIST FRACTURE 7
559 ABORTION SPONTANEOUS 6
560 ABSCESS 6
561 ACUTE HEPATIC FAILURE 6
562 AGGRESSION 6
563 ANGINA PECTORIS 6
564 APATHY 6
565 APHONIA 6
566 ATELECTASIS 6
567 BASAL CELL CARCINOMA 6
568 BEDRIDDEN 6
569 BLOOD ALKALINE PHOSPHATASE INCREASED 6
570 BODY TEMPERATURE INCREASED 6
571 BRAIN OEDEMA 6
572 BREAST PAIN 6
573 CHRONIC SINUSITIS 6
574 COLITIS ULCERATIVE 6
575 DECREASED INTEREST 6
576 DEVICE LEAKAGE 6
577 DISABILITY 6
578 DRUG ABUSE 6
579 DRUG TOLERANCE 6
580 DYSKINESIA 6
581 EYE HAEMORRHAGE 6
582 FACIAL PAIN 6
583 GASTROENTERITIS VIRAL 6
584 GASTROINTESTINAL INFECTION 6
585 GESTATIONAL HYPERTENSION 6
586 GINGIVAL BLEEDING 6
587 HAEMATOCRIT DECREASED 6
588 HAEMATOMA 6
589 HUNGER 6
590 HYPERPARATHYROIDISM SECONDARY 6
591 INFUSION SITE SWELLING 6
592 INJECTION SITE URTICARIA 6
593 INTERVERTEBRAL DISC DEGENERATION 6
594 JAUNDICE 6
595 JOINT DISLOCATION 6
596 LOCAL SWELLING 6
597 MALIGNANT MELANOMA 6
598 MENSTRUATION DELAYED 6
599 MENTAL IMPAIRMENT 6
600 METASTASES TO BONE 6
601 MOUTH ULCERATION 6
602 NEPHROPATHY 6
603 NEURALGIA 6
604 NOCTURIA 6
605 OESOPHAGEAL ULCER 6
606 OXYGEN SATURATION DECREASED 6
607 PANCREATITIS 6
608 PARALYSIS 6
609 PARANASAL SINUS DISCOMFORT 6
610 PELVIC PAIN 6
611 PERFORATED ULCER 6
612 PLATELET COUNT INCREASED 6
613 POST PROCEDURAL COMPLICATION 6
614 POST-TRAUMATIC STRESS DISORDER 6
615 PRESCRIBED UNDERDOSE 6
616 PRODUCT USED FOR UNKNOWN INDICATION 6
617 RASH PAPULAR 6
618 RENAL CYST 6
619 SKIN IRRITATION 6
620 SKIN ULCER 6
621 SMALL INTESTINAL OBSTRUCTION 6
622 SPINAL DISORDER 6
623 SPRUE-LIKE ENTEROPATHY 6
624 SYSTEMIC LUPUS ERYTHEMATOSUS 6
625 TEMPERATURE INTOLERANCE 6
626 THUNDERCLAP HEADACHE 6
627 TOOTH EXTRACTION 6
628 URINE ODOUR ABNORMAL 6
629 WALKING AID USER 6
630 ABNORMAL BEHAVIOUR 5
631 ADVERSE REACTION 5
632 AMENORRHOEA 5
633 ANKLE FRACTURE 5
634 APPENDICITIS 5
635 APPLICATION SITE PAIN 5
636 APPLICATION SITE PRURITUS 5
637 ATRIAL SEPTAL DEFECT 5
638 AURA 5
639 AUTOIMMUNE DISORDER 5
640 BACK INJURY 5
641 BIPOLAR DISORDER 5
642 BLOOD COUNT ABNORMAL 5
643 BLOOD PRESSURE ABNORMAL 5
644 BLOOD PRESSURE FLUCTUATION 5
645 BREAST CANCER 5
646 CANDIDA INFECTION 5
647 CARPAL TUNNEL SYNDROME 5
648 CLOSTRIDIUM DIFFICILE INFECTION 5
649 COELIAC DISEASE 5
650 COMPLICATION ASSOCIATED WITH DEVICE 5
651 CONVULSION 5
652 CYST 5
653 DECREASED ACTIVITY 5
654 DERMATITIS ATOPIC 5
655 DRUG-INDUCED LIVER INJURY 5
656 DYSGRAPHIA 5
657 EAR DISCOMFORT 5
658 ECCHYMOSIS 5
659 EJECTION FRACTION DECREASED 5
660 ENERGY INCREASED 5
661 ERECTILE DYSFUNCTION 5
662 ERECTION INCREASED 5
663 EXTRASYSTOLES 5
664 EYELID PTOSIS 5
665 GALLBLADDER DISORDER 5
666 GASTROINTESTINAL ULCER 5
667 GENERALISED TONIC-CLONIC SEIZURE 5
668 HAIR TEXTURE ABNORMAL 5
669 HEPATIC CYST 5
670 HEPATITIS C 5
671 HEPATOMEGALY 5
672 HORDEOLUM 5
673 HYDROCEPHALUS 5
674 HYPERCOAGULATION 5
675 HYPERLIPIDAEMIA 5
676 HYPOMAGNESAEMIA 5
677 IMMUNOSUPPRESSION 5
678 INCORRECT ROUTE OF DRUG ADMINISTRATION 5
679 INFUSION SITE ERYTHEMA 5
680 INJECTION SITE WARMTH 5
681 INTENTIONAL DRUG MISUSE 5
682 IRON DEFICIENCY ANAEMIA 5
683 LOCALISED INFECTION 5
684 LOWER LIMB FRACTURE 5
685 MOTOR DYSFUNCTION 5
686 MUSCLE ATROPHY 5
687 MUSCLE DISORDER 5
688 MUSCULOSKELETAL DISORDER 5
689 NERVOUS SYSTEM DISORDER 5
690 NO THERAPEUTIC RESPONSE 5
691 OBSTRUCTION GASTRIC 5
692 ORAL HERPES 5
693 ORAL MUCOSAL BLISTERING 5
694 OSTEOPENIA 5
695 OVERWEIGHT 5
696 PALLOR 5
697 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5
698 PREGNANCY 5
699 PRESCRIBED OVERDOSE 5
700 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5
701 PRODUCT AVAILABILITY ISSUE 5
702 PRODUCT COMMUNICATION ISSUE 5
703 PRODUCT RESIDUE PRESENT 5
704 PRODUCT TASTE ABNORMAL 5
705 PULMONARY HYPERTENSION 5
706 PULMONARY THROMBOSIS 5
707 RASH GENERALISED 5
708 RENAL TUBULAR NECROSIS 5
709 RHABDOMYOLYSIS 5
710 RIGHT VENTRICULAR FAILURE 5
711 SKIN HAEMORRHAGE 5
712 TARDIVE DYSKINESIA 5
713 TENDONITIS 5
714 TENSION 5
715 TENSION HEADACHE 5
716 THERAPY CHANGE 5
717 THERAPY PARTIAL RESPONDER 5
718 THIRST 5
719 UTERINE LEIOMYOMA 5
720 UTERINE PERFORATION 5
721 VITAMIN D DECREASED 5
722 WEIGHT FLUCTUATION 5
723 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5
724 ABNORMAL FAECES 4
725 ADHESIVE TAPE USE 4
726 ADRENAL INSUFFICIENCY 4
727 ANAPHYLACTIC SHOCK 4
728 ANGIOEDEMA 4
729 AORTIC DILATATION 4
730 APPLICATION SITE RASH 4
731 ARTERIOSCLEROSIS 4
732 ATAXIA 4
733 BLINDNESS TRANSIENT 4
734 BLOOD CAFFEINE INCREASED 4
735 BLOOD CALCIUM DECREASED 4
736 BLOOD CREATININE INCREASED 4
737 BLOOD GLUCOSE FLUCTUATION 4
738 BLOOD PRESSURE SYSTOLIC INCREASED 4
739 BLOOD TEST ABNORMAL 4
740 BLOOD VISCOSITY DECREASED 4
741 BLOOD ZINC DECREASED 4
742 BODY HEIGHT DECREASED 4
743 BONE LOSS 4
744 BONE MARROW FAILURE 4
745 BRADYCARDIA 4
746 BRAIN FOG 4
747 BRAIN INJURY 4
748 BREAST MASS 4
749 BRUXISM 4
750 CAESAREAN SECTION 4
751 CANCER PAIN 4
752 CARDIAC ARREST 4
753 CARDIAC OPERATION 4
754 CHOLECYSTECTOMY 4
755 CHOLECYSTITIS 4
756 CLUMSINESS 4
757 CLUSTER HEADACHE 4
758 COLON CANCER 4
759 DEVICE EXPULSION 4
760 DEVICE RELATED INFECTION 4
761 DEVICE RELATED SEPSIS 4
762 DIVERTICULUM 4
763 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4
764 DRUG RESISTANCE 4
765 DRUG SCREEN FALSE POSITIVE 4
766 DRUG WITHDRAWAL HEADACHE 4
767 DUODENAL ULCER 4
768 DYSTONIA 4
769 ECONOMIC PROBLEM 4
770 ECZEMA 4
771 ERYTHEMA OF EYELID 4
772 EYE DISCHARGE 4
773 FAMILY STRESS 4
774 FEELING OF BODY TEMPERATURE CHANGE 4
775 FIBULA FRACTURE 4
776 FRUSTRATION TOLERANCE DECREASED 4
777 GASTRIC ULCER PERFORATION 4
778 GASTROENTERITIS 4
779 GINGIVAL PAIN 4
780 GRAVES^ DISEASE 4
781 HAEMORRHAGIC ANAEMIA 4
782 HAIR COLOUR CHANGES 4
783 HAND FRACTURE 4
784 HEPATIC ENCEPHALOPATHY 4
785 HEPATITIS 4
786 HYPERACUSIS 4
787 HYPERGLYCAEMIA 4
788 HYPOGLYCAEMIA 4
789 HYPOXIA 4
790 ILEUS 4
791 IMPAIRED QUALITY OF LIFE 4
792 INABILITY TO AFFORD MEDICATION 4
793 INFUSION SITE HAEMORRHAGE 4
794 INTENTIONAL DOSE OMISSION 4
795 INTENTIONAL SELF-INJURY 4
796 INTERVERTEBRAL DISC DISORDER 4
797 IRON DEFICIENCY 4
798 LARGE INTESTINE PERFORATION 4
799 LARGE INTESTINE POLYP 4
800 LEUKOCYTOSIS 4
801 MALABSORPTION 4
802 MASS 4
803 MATERNAL EXPOSURE TIMING UNSPECIFIED 4
804 MEDICAL DEVICE SITE PAIN 4
805 METABOLIC ACIDOSIS 4
806 METRORRHAGIA 4
807 MULTIPLE ALLERGIES 4
808 MULTIPLE FRACTURES 4
809 MUSCLE STRAIN 4
810 MYOPATHY 4
811 NAIL DISORDER 4
812 NERVE INJURY 4
813 NEUTROPHIL COUNT DECREASED 4
814 NON-HODGKIN^S LYMPHOMA 4
815 NONSPECIFIC REACTION 4
816 OBESITY 4
817 ORAL DISORDER 4
818 OTORRHOEA 4
819 PAIN OF SKIN 4
820 PANCREATITIS ACUTE 4
821 PAPULE 4
822 PARANOIA 4
823 PARAPLEGIA 4
824 PARTIAL SEIZURES 4
825 PEPTIC ULCER 4
826 PERICARDIAL EFFUSION 4
827 PHARYNGEAL SWELLING 4
828 POST PROCEDURAL INFECTION 4
829 PRE-ECLAMPSIA 4
830 PREMATURE LABOUR 4
831 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4
832 PRODUCT PACKAGE ASSOCIATED INJURY 4
833 PRODUCT PRESCRIBING ERROR 4
834 PRODUCT PRESCRIBING ISSUE 4
835 PRODUCT TAMPERING 4
836 PROSTATIC SPECIFIC ANTIGEN INCREASED 4
837 RENAL FAILURE ACUTE 4
838 RHINITIS 4
839 SCAB 4
840 SENSORY LOSS 4
841 SINUS HEADACHE 4
842 SKIN ATROPHY 4
843 SKIN TIGHTNESS 4
844 SKIN WARM 4
845 SNEEZING 4
846 SPLENOMEGALY 4
847 SUNBURN 4
848 SUSPECTED COUNTERFEIT PRODUCT 4
849 SYNOVIAL CYST 4
850 TIBIA FRACTURE 4
851 TOOTH ABSCESS 4
852 TORTICOLLIS 4
853 TRICUSPID VALVE INCOMPETENCE 4
854 UMBILICAL HERNIA 4
855 UROSEPSIS 4
856 VISUAL FIELD DEFECT 4
857 WEIGHT BEARING DIFFICULTY 4
858 ABNORMAL LOSS OF WEIGHT 3
859 ACNE CYSTIC 3
860 AFFECT LABILITY 3
861 ALLERGY TO ANIMAL 3
862 ANAL HAEMORRHAGE 3
863 ANEURYSM 3
864 ANGLE CLOSURE GLAUCOMA 3
865 ANIMAL BITE 3
866 ANKYLOSING SPONDYLITIS 3
867 ANOGENITAL WARTS 3
868 ANORECTAL DISCOMFORT 3
869 APPARENT DEATH 3
870 ARTHRITIS INFECTIVE 3
871 ARTHROPOD STING 3
872 ATROPHY 3
873 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3
874 BACTERIAL INFECTION 3
875 BLADDER PAIN 3
876 BLINDNESS UNILATERAL 3
877 BLOOD GLUCOSE ABNORMAL 3
878 BLOOD HIV RNA INCREASED 3
879 BLOOD PRESSURE INADEQUATELY CONTROLLED 3
880 BLOOD SODIUM DECREASED 3
881 BLOOD THYROID STIMULATING HORMONE INCREASED 3
882 BODY TEMPERATURE DECREASED 3
883 BONE DENSITY DECREASED 3
884 BRAIN NATRIURETIC PEPTIDE INCREASED 3
885 BRAIN OPERATION 3
886 CALCIUM DEFICIENCY 3
887 CARDIAC FLUTTER 3
888 CAROTID ARTERY STENOSIS 3
889 CATHETER SITE HAEMORRHAGE 3
890 CEREBRAL INFARCTION 3
891 CHEILITIS 3
892 CHOKING SENSATION 3
893 COLD SWEAT 3
894 CONCOMITANT DISEASE AGGRAVATED 3
895 CREATININE RENAL CLEARANCE DECREASED 3
896 CYANOSIS 3
897 DECUBITUS ULCER 3
898 DEMENTIA ALZHEIMER^S TYPE 3
899 DERMATITIS 3
900 DEVICE BREAKAGE 3
901 DEVICE OCCLUSION 3
902 DEVICE USE ERROR 3
903 DEVICE USE ISSUE 3
904 DIZZINESS POSTURAL 3
905 DRUG LEVEL DECREASED 3
906 DRUG USE DISORDER 3
907 DYSPHEMIA 3
908 EAR DISORDER 3
909 ELECTROCARDIOGRAM QT PROLONGED 3
910 EMERGENCY CARE 3
911 ENURESIS 3
912 EOSINOPHILIA 3
913 ESCHERICHIA INFECTION 3
914 EYE INFECTION 3
915 FACE INJURY 3
916 FACE OEDEMA 3
917 FACIAL BONES FRACTURE 3
918 FAT TISSUE INCREASED 3
919 FLANK PAIN 3
920 FOETAL HEART RATE DECELERATION ABNORMALITY 3
921 FOLLICULITIS 3
922 FOOT DEFORMITY 3
923 FOREIGN BODY 3
924 FREQUENT BOWEL MOVEMENTS 3
925 FULL BLOOD COUNT ABNORMAL 3
926 FUNGAL SKIN INFECTION 3
927 GASTRIC CANCER 3
928 GASTRIC OPERATION 3
929 GASTROINTESTINAL MOTILITY DISORDER 3
930 GASTROINTESTINAL SOUNDS ABNORMAL 3
931 GINGIVAL ERYTHEMA 3
932 GINGIVITIS 3
933 GLUCOSE TOLERANCE IMPAIRED 3
934 GRIP STRENGTH DECREASED 3
935 GROIN PAIN 3
936 HAEMORRHAGE INTRACRANIAL 3
937 HAIR DISORDER 3
938 HALLUCINATION, AUDITORY 3
939 HANGOVER 3
940 HEARING IMPAIRED 3
941 HEART RATE ABNORMAL 3
942 HEMIPLEGIC MIGRAINE 3
943 HEPATIC NECROSIS 3
944 HEPATIC PAIN 3
945 HEPATITIS ACUTE 3
946 HERPES VIRUS INFECTION 3
947 HIP SURGERY 3
948 HOSPICE CARE 3
949 HUMERUS FRACTURE 3
950 HYDRONEPHROSIS 3
951 HYPERAESTHESIA 3
952 HYPERCALCAEMIA 3
953 HYPERKERATOSIS 3
954 HYPERREFLEXIA 3
955 HYPERTHYROIDISM 3
956 HYPERTONIC BLADDER 3
957 HYPERVENTILATION 3
958 HYPOKINESIA 3
959 HYPOREFLEXIA 3
960 HYSTERECTOMY 3
961 IMMUNODEFICIENCY 3
962 INCORRECT DOSE ADMINISTERED BY DEVICE 3
963 INFUSION SITE BRUISING 3
964 INFUSION SITE PRURITUS 3
965 INFUSION SITE RASH 3
966 INJECTION SITE INDURATION 3
967 INJECTION SITE IRRITATION 3
968 INJURY ASSOCIATED WITH DEVICE 3
969 INTERMENSTRUAL BLEEDING 3
970 INTERNAL HAEMORRHAGE 3
971 INTRAOCULAR PRESSURE INCREASED 3
972 ISCHAEMIC STROKE 3
973 KNEE ARTHROPLASTY 3
974 LARYNGITIS 3
975 LARYNGITIS FUNGAL 3
976 LOCALISED OEDEMA 3
977 LOW DENSITY LIPOPROTEIN INCREASED 3
978 LUNG NEOPLASM MALIGNANT 3
979 LYMPH NODE PAIN 3
980 LYMPHOCYTE PERCENTAGE DECREASED 3
981 LYMPHOEDEMA 3
982 MADAROSIS 3
983 MAJOR DEPRESSION 3
984 MATERNAL EXPOSURE BEFORE PREGNANCY 3
985 MELAENA 3
986 MELANOCYTIC NAEVUS 3
987 MIDDLE EAR EFFUSION 3
988 MYOCARDIAL ISCHAEMIA 3
989 MYOSITIS 3
990 NEAR DEATH EXPERIENCE 3
991 NEEDLE ISSUE 3
992 NEOPLASM 3
993 NODULE 3
994 NONREASSURING FOETAL HEART RATE PATTERN 3
995 ONYCHOMYCOSIS 3
996 ORTHOSTATIC HYPOTENSION 3
997 OSTEONECROSIS OF JAW 3
998 PANCYTOPENIA 3
999 PARANASAL SINUS HYPERSECRETION 3